Industry Headlines: Page 381

Acreage Holdings Adds Former Time Warner Telecom CEO Larissa Herda, Former IBM CFO Douglas Maine to Its Board of Directors

The appointments are part of the multi-state cannabis operator's public offering on the Canadian Stock Exchange.

Cannabis Company Backed by Retail Fortune Eyes East Coast Expansion

Green Growth Brands prepares to be publicly traded in Canada.

Canada Signs On to U.S.-Led Renewal of War on Drugs

Canada was rebuked by a group of world leaders and experts on drug policy for endorsing a Trump-led declaration renewing the “war on drugs."

Canadian Cannabis Company, The Flowr Corporation, To Begin Trading on the TSX Venture Exchange

The licensed producer is focused on growing premium cannabis and is rapidly scaling operations to meet medicinal and adult-use demand.

High Times Acquires DOPE Magazine, Localizing West Coast Advertising Opportunities

The brand is further expanding its media empire and acquiring an expert team.

Sonoma County Cracks Down on Illegal Cannabis Grows

Since January 2017, Sonoma County Code Enforcement has received 682 complaints of cannabis production on private property.

Pennsylvania Med Schools Granted Status for Medical Marijuana Research

Eight schools were chosen, and five of them are in Philadelphia.

FSD Pharma Receives First Delivery of Canntab Equipment

The company has the capacity to manufacture approximately 1,500,000 tablets per day.

Trait Unveils Executive Team, Closes CAD$12.3 Million Private Placement

The funds will be used to develop novel, water-soluble cannabinoid products and advance research on pesticide-free, ultrahigh-yield cannabis plants.

Shoppers Drug Mart Now a Licensed Medical Marijuana Producer

The pharmacy giant will now be able to dispense medical cannabis to patients.

It's Not Just Cannabis Stocks--Salaries and Jobs in Legal Marijuana are Climbing Too

Cannabis jobs are on the rise and salaries are increasing, according to a new report by the California-based employment agency Vangst.

FSD Pharma and SciCann Therapeutics Launch Cardiovascular Research Program in Tel Aviv University

The new research program is aimed at the development of novel and proprietary cannabinoid-based treatments for the prevention and treatment of atherosclerosis.

Previous Page

Page 381 of 655

Next Page